Recent studies on colorectal cancer have demonstrated that aspirin exerts an anti-tumor metastatic effect by inhibiting the TXA2-ARHGEF1 signaling pathway and enhancing T cell anti-tumor immunity [99]. This evidence concerns the gene ARHGEF1 and neoplasm.